AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (April 6, 2007). doi:10.1152/ajpheart.00166.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/H743    most recent
00166.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monden, Y.
Right arrow Articles by Sunagawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monden, Y.
Right arrow Articles by Sunagawa, K.
Submitted on February 8, 2007
Accepted on April 3, 2007

Tumor necrosis factor-{alpha} is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction

Yoshiya Monden1, Toru Kubota1*, Takahiro Inoue1, Takaki Tsutsumi1, Shunichi Kawano1, Tomomi Ide1, Hiroyuki Tsutsui2, and Kenji Sunagawa1

1 Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka-shi, Fukuoka-ken, Japan
2 Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo-shi, Hokkaido, Japan

* To whom correspondence should be addressed. E-mail: kubotat{at}cardiol.med.kyushu-u.ac.jp.

Tumor necrosis factor (TNF)-{alpha} induced in damaged myocardium has been considered to be cardiotoxic. TNF-{alpha} initiates its biological effects by binding two distinct receptors; R1 (p55) and R2 (p75). Although TNF-{alpha} has been shown to be cardiotoxic via R1-mediated pathways, little is known about the roles of R2-mediated pathways in myocardial infarction (MI). We created MI in R1-knockout (KO), R2KO, and wild type (WT) mice by ligating the left coronary artery. Functional, histological, and biochemical analyses were performed 4 weeks after ligation. Although infarct size was not different among WT, R1KO, and R2KO mice, post-MI survival was significantly improved in R1KO but not R2KO mice. R1KO significantly ameliorated contractile dysfunction after MI, while R2KO significantly exaggerated ventricular dilatation and dysfunction. Myocyte hypertrophy and interstitial fibrosis in non-infarct myocardium was exacerbated in R2KO but not in R1KO mice. Expression of R1, which was not affected by MI and was nullified in R1KO mice, was significantly up-regulated in R2KO mice. In contrast, expression of R2, which was significantly up-regulated by MI and was nullified in R2KO mice, was unaffected in R1KO mice. Meanwhile, TNF-{alpha} expression, which was significantly up-regulated in non-infarct myocardium after MI, was not affected by R1KO or R2KO. However, transcript levels of IL-6, IL-1{beta}, TGF-{beta}, and MCP-1, which were significantly up-regulated after MI, were significantly down-regulated in R1KO mice. In contrast, transcript levels of IL-6 and IL-1{beta} were significantly further up-regulated in R2KO mice. TNF-{alpha} is toxic via R1 and protective via R2 in a murine model of MI. Selective blockade of R1 may be a candidate therapeutic intervention for cardiovascular diseases.




This article has been cited by other articles:


Home page
Lab MedHome page
K. Hoetzenecker, C. Adlbrecht, M. Lichtenauer, S. Hacker, W. Hoetzenecker, A. Mangold, S. Nickl, A. Mitterbauer, M. Zimmermann, I. M. Lang, et al.
Levels of sCD40, sCD40L, TNF{alpha}, and TNF-RI in the Culprit Coronary Artery During Myocardial Infarction
Lab Med, November 1, 2009; 40(11): 660 - 664.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Lacerda, S. Somers, L. H. Opie, and S. Lecour
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Cardiovasc Res, November 1, 2009; 84(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. E. Fildes, S. M. Shaw, N. Yonan, and S. G. Williams
The Immune System and Chronic Heart Failure: Is the Heart in Control?
J. Am. Coll. Cardiol., March 24, 2009; 53(12): 1013 - 1020.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Schulz and G. Heusch
Tumor Necrosis Factor-{alpha} and Its Receptors 1 and 2: Yin and Yang in Myocardial Infarction?
Circulation, March 17, 2009; 119(10): 1355 - 1357.
[Full Text] [PDF]


Home page
CirculationHome page
M. Wang, P. R. Crisostomo, T. A. Markel, Y. Wang, and D. R. Meldrum
Mechanisms of Sex Differences in TNFR2-Mediated Cardioprotection
Circulation, September 30, 2008; 118(14_suppl_1): S38 - S45.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. Plaisance, C. Morandi, C. Murigande, and M. Brink
TNF-{alpha} increases protein content in C2C12 and primary myotubes by enhancing protein translation via the TNF-R1, PI3K, and MEK
Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E241 - E250.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.